EcoDrugPlus

Cyclin Dependent Kinase 4

Ensembl ID : ENSBSLG00000002570
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSBSLG00000023063
Gene Symbol: CDK5
3 Cross references
168 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSBSLG00000010266
Gene Symbol: CDK6
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSBSLG00000005258
Gene Symbol: CDK7
3 Cross references
219 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSBSLG00000016348
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSBSLG00000009972
Gene Symbol: CYSLTR1
3 Cross references
180 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSBSLG00000008635
Gene Symbol: LOC114846450
3 Cross references
194 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSBSLG00000001153
Gene Symbol: LOC114858441
2 Cross references
494 Possible Orthologues:

Cytochrome P450 3a30-Like

Ensembl ID : ENSBSLG00000026068
Gene Symbol: LOC114870620
3 Cross references
561 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSBSLG00000001062
Gene Symbol: LOC114858446
3 Cross references
573 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSBSLG00000013458
Gene Symbol: LOC114859104
2 Cross references
470 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSBSLG00000004445
Gene Symbol: CYP19A1
3 Cross references
246 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).